Searching recalls…
Searching…
Searching…
Home › Prescription medicine › Astellas Pharma US Inc. — Prograf (tacrolimus)…
Do not stop taking this without speaking to your pharmacist or doctor.
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
The Recall Registry rates this highest risk — FDA Class I: reasonable probability of serious harm or death.
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: Astellas Pharma US Inc.
Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
Nationwide in the USA
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Astellas Pharma US Inc. — Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine